Sean Murphy joined TriSalus as Chief Financial Officer in June 2022. Sean has 40+ years of experience in healthcare operations and business development, encompassing pharmaceuticals, medical devices, and diagnostics. He was appointed a director of TriSalus in September 2021, after serving as Executive Vice President of Malin Life Sciences Holdings. A publicly traded investment company, Malin invested in a portfolio of companies that included pharmaceuticals, medical devices, and healthcare services. Additionally, Sean has been a Senior Advisor at Evercore Partners, a leading investment-banking advisory firm. He was also Head of Corporate M&A and Business Development at Abbott Laboratories, where, over 30 years with the company, he played a leading role in strategic and operational investments. Currently, he serves on the board of directors of several life science companies, including Radius Health, Immucor Diagnostics, Xenex and Prenosis.
A CPA, Sean earned an MS in Finance from the University of Illinois and a BBA from Western Illinois University.